Sienna Biopharmaceuticals, Inc. — Net Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d26db71b-52c8-448d-86c6-c77937129d22/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-73.5M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-074162 |
| FY 2017 | $-50.5M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-084145 |
| FY 2016 | $-21.2M | 2016-01-01 – 2016-12-31 | evidence 0001193125-18-084145 |
| FY 2015 | $-11.3M | 2015-01-01 – 2015-12-31 | evidence 0001193125-18-084145 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Sienna Biopharmaceuticals, Inc. — all facts · Operating Income